Altos Labs is a biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. The company comprises a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission. Altos has operations in the San Francisco Bay Area and San Diego, and in Cambridge, UK, with significant collaborations in Japan.
BioRender is the world's first tool designed to help scientists create and share professional scientific figures quickly and easily. With a library of over 50,000 icons and templates across more than 30 fields of life sciences, BioRender enables users to produce high-quality visuals without requiring any drawing or design skills. The platform is used by over 2.5 million scientists and 1,500 leading institutions, showcasing its strong traction and market position in the science communication space. BioRender's unique offering lies in its intuitive drag-and-drop functionality and customizable templates, making it a go-to solution for researchers looking to effectively communicate their findings.
Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.
Gencove is a pioneering software platform that offers high-throughput, cost-effective genome sequencing through low-pass sequencing technology. Their solutions cater to academic institutions, clinical laboratories, and companies in agriculture and pharmaceuticals, enabling them to obtain complete genomic information efficiently. Gencove differentiates itself by providing a hardware-agnostic service that streamlines genomic data processing, making it accessible for various applications, including human genomics and plant and animal genomics. The company is focused on advancing global health and sustainability by unlocking the value of genetic data, and it has established partnerships with industry leaders to enhance its market position.
Moleculent is on a mission to develop technology-enabled products that leverage new insights into the molecular foundation of human biology. Developing amazing products to advance human health gives you purpose. they believe that our understanding of the molecular basis of human biology, in health and disease will increase radically in the coming ten years. This will lead to a vast improvement in therapies, diagnostics, and a new, fundamental understanding
Nodexus is a Venture- and SBIR-backed biotech startup commercializing the NX One platform to address widespread unmet needs for accessible live single cell isolation in industrial/biopharma, clinical research, and academic sectors. The NX One platform consists of a low-infrastructure, low-cost hardware system and single-use disposable microfluidic cartridges tailored toward live single-cell workflows involving gene editing (e.g. CRISPR engineering), cell line/antibody development, and tumor heterogeneity studies.